Cargando…
A Phase I, Randomized, Double-Blind, Laser-Evoked Potential Study to Evaluate the Analgesic/Antihyperalgesic Effect of ASP9226, a State-Dependent N-Type Voltage-Gated Calcium Channel Inhibitor, in Healthy Male Subjects
OBJECTIVE: Evaluate the analgesic/antihyperalgesic effects of ASP9226, a state-dependent N-type voltage-gated calcium channel inhibitor, in healthy male subjects. DESIGN: Randomized, double-blind, double-dummy, placebo- and active comparator–controlled crossover study. SETTING: HPR Dr. Schaffler Gmb...
Autores principales: | Schaffler, Klaus, He, Weizhong, Passier, Paul, Tracy, Katherine, Fakhoury, Allam, Paul, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217710/ https://www.ncbi.nlm.nih.gov/pubmed/29378016 http://dx.doi.org/10.1093/pm/pnx338 |
Ejemplares similares
-
A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects
por: Schaffler, Klaus, et al.
Publicado: (2018) -
Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry
por: Ueberall, Michael A, et al.
Publicado: (2021) -
The Capsaicin 8% Patch for Neuropathic Pain in Clinical Practice: A Retrospective Analysis
por: Wagner, Till, et al.
Publicado: (2013) -
Burden of Illness Associated with Peripheral and Central Neuropathic Pain among Adults Seeking Treatment in the United States: A Patient-Centered Evaluation
por: Schaefer, Caroline, et al.
Publicado: (2014) -
Effect of Combined Diclofenac and B Vitamins (Thiamine, Pyridoxine, and Cyanocobalamin) for Low Back Pain Management: Systematic Review and Meta-analysis
por: Calderon-Ospina, Carlos-Alberto, et al.
Publicado: (2020)